Galcanezumab Safe, Effective for Reducing Monthly Migraine Headache Days

In patients with chronic migraine, monthly subcutaneous injections of galcanezumab at 120- and 240-mg doses were more effective than placebo for lowering the number of monthly migraine headache days.

Source link

Related posts

Friendship Bench—A Model for Accessible Mental Health Care


Exceptional involvement of medulla oblongata in Wilson disease


Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy